Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Notes Payables: 2020

Historic Notes Payables for Whitehawk Therapeutics (WHWK) over the last 1 years, with Dec 2020 value amounting to $9.0 million.

  • Whitehawk Therapeutics' Notes Payables was N/A to $9.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $9.0 million, marking a year-over-year change of. This contributed to the annual value of $9.0 million for FY2020, which is N/A change from last year.
  • Per Whitehawk Therapeutics' latest filing, its Notes Payables stood at $9.0 million for FY2020.
  • Over the past 5 years, Whitehawk Therapeutics' Notes Payables peaked at $9.0 million during FY2020, and registered a low of $9.0 million during FY2020.
  • For the 1-year period, Whitehawk Therapeutics' Notes Payables averaged around $9.0 million, with its median value being $9.0 million (2020).